Browsing: Face

Novo Nordisk must face part of a securities fraud lawsuit accusing the drugmaker of misleading investors about dosing and tolerability in a late-stage clinical trial for CagriSema, after a federal judge allowed a narrower set of shareholder claims to move forward

Novo Nordisk will need to answer allegations that it potentially defrauded shareholders over the next-generation weight loss therapy CagriSema

Weight loss jabs such as Wegovy and Mounjaro have boomed in popularity, and so have reports of myriad side-effects. This week researchers have suggested GLP-1 medications could be associated with hair loss

Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known

This is read by an automated voice. Please report any issues or inconsistencies here

Mirage News Mirage News Mirage NewsNational24 Jul 2026 1:14 am AESTDate Time UCLA

The increased use of weight-loss drugs has created a big opportunity for aesthetics company Galderma, its CEO told CNBC on Thursday

Young women are leading a worrying increase in early-onset type 2 diabetes diagnoses in England, according to a new analysis

“Obtaining regulatory approval is one part of the challenge for rare disease therapies. Following approval, HTA agencies and payers evaluate the clinical, economic, and patient-centered value of a therapy to inform pricing, reimbursement, and patient access decisions. Historically, rare disease trials have often relied on small patient populations, single-arm or open-label designs, surrogate endpoints, and…

Comments submitted to the agencies reveal a growing divide between public health groups that urge FDA and USDA to move quickly and industry organizations that argue existing frameworks are too broad